Skip to main content

Table 2 Summary of the main parameters of the baseline laboratory and echocardiographic findings. There was no significant difference between the two groups regarding the laboratory and echocardiographic parameters

From: Analysis of cardiovascular mortality, bleeding, vascular and cerebrovascular events in patients with atrial fibrillation vs. sinus rhythm undergoing transfemoral Transcatheter Aortic Valve Implantation (TAVR)

Baseline laboratory Total population (n = 257) SR-group(n = 148) AF-group(n = 109) p Value
Hemoglobin (mmol/l) 7.5 ± 1.1 7.5 ± 1.1 7.4 ± 1.1 0.227
Creatinin (umol/l1) 108.1 ± 44.1 103.5 ± 37.1 114.2 ± 51.3 0.121*
Glomerular filtration rate CKD-EPI (ml/min1) 54.5 ± 19.2 54.9 ± 17.9 54.0 ± 20.9 0.718
Thrombocyte (Gpt/l) 222.5 ± 75.6 225.3 ± 77.5 218.6 ± 73.2 0.479
Echocardiographic parameters Total population (n = 257) SR-group (n = 148) AF-group (n = 109) p Value
Aortic valve area (cm2) 0.72 ± 0.17 0.72 ± 0.17 0.71 ± 0.16 0.799
Pulmonary hypertension (PaSP >55 mmHg) 23 (8.9%) 11 (7.4%) 12 (11.0%) 0.379
Ejection fraction (%) 46.1 ± 13.8 47.2 ± 13.7 44.5 ± 13.9 0.113
Ejection fraction <40% 59 (23.0%) 30 (20.3%) 29 (26.6%) 0.293
  1. 1Patients not requiring dialysis (n = 8; 3.1% or SR: n = 7; 4.7% AF: n = 1, 0.9%). * Test using log-transformed values
  2. All values correspond to the mean ± standard deviation or the number n (proportion in %)